ARIAD PHARMACEUTICALS INC Proceeds from Warrant Exercises
ARIAD PHARMACEUTICALS INC reported Proceeds from Warrant Exercises of $12.48 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2015-03-02
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for the quarter ending 2012-12-31 was $1.00K, a 0.00% change year-over-year.
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for the quarter ending 2012-06-30 was -$18.00K.
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for the quarter ending 2012-03-31 was $12.50M, a 64.91% increase year-over-year.
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for fiscal 2012 was $12.48M, a 54.49% increase from fiscal 2011.
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for fiscal 2011 was $8.08M, a 210.77% increase from fiscal 2010.
- ARIAD PHARMACEUTICALS INC proceeds from warrant exercises for fiscal 2010 was $2.60M.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 3 month as first filed | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month | Proceeds from Warrant Exercises 12 month as first filed |
|---|---|---|---|---|---|---|
| 2012-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.00K derived: sum of 2 quarters · filed 2015-03-02 | -$17.00K derived: sum of 3 quarters · filed 2015-03-02 | $12.48M 10-K · filed 2015-03-02 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$18.00K derived: sum of 2 quarters · filed 2013-11-12 | $12.48M 10-Q · filed 2013-11-12 | $12.48M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2012-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $12.48M 10-Q · filed 2013-08-09 | $12.48M derived: sum of 3 quarters · filed 2014-03-03 | $12.98M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2012-03-31 | $12.50M 10-Q · filed 2013-11-12 | $12.48M 10-Q · filed 2012-05-09 | $12.50M derived: sum of 2 quarters · filed 2014-03-03 | $13.00M derived: sum of 3 quarters · filed 2014-03-03 | $13.00M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2011-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $500.00K derived: sum of 2 quarters · filed 2014-03-03 | $500.00K derived: sum of 3 quarters · filed 2014-03-03 | $8.08M 10-K · filed 2014-03-03 | ||
| 2011-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $499.00K derived: sum of 2 quarters · filed 2012-11-09 | $8.08M 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $7.58M 10-Q · filed 2012-08-09 | ||||
| 2011-03-31 | $7.58M 10-Q · filed 2012-05-09 | |||||
| 2010-12-31 | $2.60M 10-K · filed 2014-03-03 | $2.62M 10-K · filed 2012-02-29 |